Katja Weisel, MD

Dr. Weisel on INSIGHT MM Analysis of Duration of Therapy in Myeloma

September 14th 2019

Katja Weisel, MD, myeloma specialist at the University of Tübingen, discusses an analysis of the INSIGHT MM study evaluating fixed-duration versus continuous therapy for patients with multiple myeloma.